Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

The Pharmaceutical Market: Egypt

Espicom Healthcare Intelligence
September 30, 2009
38 Pages - Pub ID: ESPI2495245
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Countries covered: Egypt

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.

Additional Information

The Egyptian pharmaceutical market is the largest in the region, worth an estimated US$2.2 billion in 2008. Pharmaceutical sector activity centres around two major areas: the introduction of WTO TRIPS-compliant legislation on intellectual property rights, and the state of the drug pricing system. These issues have caused much friction between the government, local producers and multinationals; local producers face challenges complying with IP laws.

Egypt is a leading exporter to Arab, Asian and African regions, although exports have declined in recent years. Rising costs for imported raw materials, due to currency depreciation, have acted as a brake on local production. Annual market growth is around 5.0% in US dollar terms.

Privatisation is a growing trend within the Egyptian healthcare industry, thus the sector is undergoing considerable change. Prior to the 1990s, the sector was predominantly State-controlled, with the private sector playing only a minimal role in the provision of healthcare.

The private sector now plays an increasingly important role in healthcare provision, emerging largely as a result of the declining standard of public sector care. Out-of-pocket payments for drugs have also increased in recent years.

Related Reports:
Walgreen Co (WAG) Profile & Health Care Industry Trends Analysis 2010
Snapshots Hungary Pharmaceuticals 2009
Snapshots Venezuela Pharmaceuticals 2009
Snapshots US Pharmaceuticals 2009
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
Snapshots South Africa Pharmaceuticals 2009
Snapshots Spain Pharmaceuticals 2009
Snapshots Poland Pharmaceuticals 2009
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Kenya Pharmaceuticals and Healthcare Report Q1 2010

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 2